Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags Technology Progyny Inc Oscar Health Inc
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Weight management Companies Health & Science
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Boeing Co Markets Starbucks Corp
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags US: News Business Biotechnology
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Breaking News: Europe Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Business News Biotech and Pharmaceuticals Roche Holding AG
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags BE Semiconductor Industries NV Novo Nordisk A/S Prices
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Novo Nordisk A/S Social issues Healthy Returns
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Social issues Healthy Returns LILLY DRN
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Biotech and Pharmaceuticals Business News Health care industry
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Social media Obesity Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Healthy Returns AstraZeneca PLC Bristol/Myers Squibb Co
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Pharmaceuticals Goodrx Holdings Inc Biotechnology
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Investment strategy Microstrategy Inc NVIDIA Corp
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Companies Health & Science Science
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Technology 5 Things to Know Business News
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags LILLY DRN Science Breaking News: Business
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags LILLY DRN Companies Health & Science
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Social issues AstraZeneca PLC Healthy Returns
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Healthy Returns Community Health Systems Inc Social issues
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Pharmaceuticals Breaking news Novo Nordisk A/S
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Obesity Novo Nordisk A/S Biotechnology
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags wegovy Benzinga Ozempic
From Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Microsoft Corp Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags Novo Nordisk A/S US: News Business
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags LILLY DRN Health care industry Health & Science
From CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
Tags Investing Business Novo Nordisk A/S
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Pharmaceuticals Zealand Pharma A/S LILLY DRN
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
Tags CNBC Investigations Health & Science Business
From CNBC.com News
CNBC Daily Open: October’s gravity bringing stocks down
Tickers JOBS OIL
Tags Oil Markets NVIDIA Corp
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.